The experience of using the placenta hydrolyzate in women with climacteric syndrome in perimenopausal period
This article presents the results of randomized, blind, placebo-controlled prospective study in parallel groups. 40 premenopausal women with symptoms of climacteric syndrome, menstrual disordersand FSH level more than 20 mIu/ml, were recruited and randomized into 2 groups: 20 women (group 1) used pl...
Saved in:
Main Authors: | I I Kovalenko (Author), A V Atalyan (Author) |
---|---|
Format: | Book |
Published: |
IP Berlin A.V.,
2016-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Evaluation of efficiency of correction climacteric syndrome in women of perimenopausal period with reproductive disturbances in anamnesis
by: С. О. Шурпяк, et al.
Published: (2017) -
The use of human placenta hydrolyzate in the treatment of insufficient endometrial proliferation
by: I V Kuznetsova, et al.
Published: (2013) -
Prevalence of climacteric symptoms comparing perimenopausal and postmenopausal Chinese women
by: Xiangyan Ruan, et al.
Published: (2017) -
Effectiveness of the human placenta hydrolyzate in the treatment of menopausal symptoms in women in the menopausal transition
by: I V Kuznetsova, et al.
Published: (2013) -
CONTRACEPTION IN THE LATE REPRODUCTIVE AND PRE-CLIMACTERIC PERIODS
by: I. O. Makarov, et al.
Published: (2016)